VBS President Thomas A. Albini, MD, asks David Almeida, MD, MBA, PhD, to summarize his presentation, which was based on a recent paper. In challenging endophthalmitis cases that develop after intravitreal injections, Dr. Almeida says that regardless of whether patients received immediate tap and inject or had immediate vitrectomy, their 6-month visual acuity outcomes were the same. He also talks about how he applies lessons learned to new cases in his practice. Click Here to see Dr. Almeida's video.
Endophthalmitis • Intravitreal Injection